X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
female (21) 21
index medicus (18) 18
hematology (17) 17
male (16) 16
oncology (16) 16
infant (15) 15
child (14) 14
child, preschool (14) 14
adolescent (12) 12
children (12) 12
pediatrics (11) 11
retrospective studies (8) 8
risk factors (7) 7
stem cells (7) 7
acute lymphoblastic leukemia (6) 6
cancer (6) 6
mutation (6) 6
transplantation (6) 6
blood (5) 5
hematopoietic stem cells (5) 5
infant, newborn (5) 5
leukemia (5) 5
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (5) 5
prognosis (5) 5
abnormalities (4) 4
disease-free survival (4) 4
health aspects (4) 4
hematopoietic stem cell transplantation (4) 4
trial (4) 4
acute lymphatic leukemia (3) 3
acute myeloid-leukemia (3) 3
adult (3) 3
analysis (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
chemotherapy (3) 3
japan (3) 3
mutations (3) 3
myeloid leukemia (3) 3
precursor cell lymphoblastic leukemia-lymphoma - pathology (3) 3
therapy (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
acute lymphoblastic-leukemia (2) 2
acute lymphocytic leukemia (2) 2
acute myeloid leukemia (2) 2
adolescents (2) 2
age of onset (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
asian continental ancestry group (2) 2
bifunctional enzyme (2) 2
bone marrow - metabolism (2) 2
bone marrow transplantation (2) 2
cbl (2) 2
cells (2) 2
chemotherapy, adjuvant (2) 2
childhood (2) 2
childhood all (2) 2
childhood leukemia (2) 2
colpocephaly (2) 2
comparative analysis (2) 2
cyclosporine - administration & dosage (2) 2
diseases (2) 2
doxorubicin - administration & dosage (2) 2
doxorubicin - analogs & derivatives (2) 2
features (2) 2
follow-up (2) 2
follow-up studies (2) 2
gene deletion (2) 2
gene rearrangement (2) 2
gene rearrangements (2) 2
genetic aspects (2) 2
graft-versus-host disease (2) 2
graft‐versus‐host disease (2) 2
hematopoietic stem cell transplantation - adverse effects (2) 2
histiocytosis (2) 2
hyper-ige syndrome (2) 2
immunology (2) 2
immunosuppressive agents - administration & dosage (2) 2
immunosuppressive agents - therapeutic use (2) 2
inborn-errors (2) 2
killer cells, natural - pathology (2) 2
leukemia, myelomonocytic, juvenile - genetics (2) 2
lymphocytes (2) 2
lymphoma (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
minimal residual disease (2) 2
neoplasm proteins - metabolism (2) 2
neoplasm, residual (2) 2
non-hodgkins-lymphoma (2) 2
pediatric-oncology-group (2) 2
peroxisome (2) 2
polymerase chain reaction (2) 2
precursor cell lymphoblastic leukemia-lymphoma - epidemiology (2) 2
precursor cell lymphoblastic leukemia-lymphoma - genetics (2) 2
precursor cell lymphoblastic leukemia-lymphoma - mortality (2) 2
pseudo-zellweger syndrome (2) 2
radiography (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2016, Volume 113, Issue 51, pp. E8277 - E8285
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 09/2019, Volume 46, Issue 9, pp. 812 - 815
Journal Article
Journal Article
Journal Article
Molecular Genetics and Metabolism Reports, ISSN 2214-4269, 2014, Volume 1, Issue 1, pp. 31 - 41
Mucopolysaccharidosis IVA (MPS IVA) is one of the lysosomal storage diseases. It is caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase.... 
GALNS | Bone marrow transplantation | Respiratory function | Bone mineral density | Mucopolysaccharidosis IVA
Journal Article
Journal Article
Molecular Genetics and Metabolism, ISSN 1096-7192, 02/2014, Volume 111, Issue 2, pp. S104 - S104
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4111 - 4111
Abstract Chronic mucocutaneous candidiasis (CMCD) is a rare congenital disorder characterized by persistent or recurrent skin, nails and mucosal membranes... 
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 02/2015, Volume 62, Issue 2, pp. 291 - 298
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1973 - 1980
Abstract We report the long-term morbidity and mortality of 105 pediatric patients who developed chronic graft-versus-host disease (cGVHD) after allogeneic... 
Hematology, Oncology and Palliative Medicine | Chronic graft-versus-host disease | Children | Functional impairment | National Institutes of Health consensus criteria | Performance status | Nonrelapse mortality | BONE-MARROW | UNRELATED DONORS | RELAPSE RISK EVIDENCE | CHILDHOOD LEUKEMIA | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | TRANSPLANTATION | IMPACT | CMV REACTIVATION | HEMATOLOGY | SURVIVORS | SEVERITY | BLOOD | Graft vs Host Disease - therapy | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | United States | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Infant | Male | Hematologic Neoplasms - pathology | Graft vs Host Disease - immunology | Transplantation, Homologous | National Institutes of Health (U.S.) | Graft vs Host Disease - mortality | Female | Retrospective Studies | Transplantation Conditioning - methods | Child | Infant, Newborn | Severity of Illness Index | Histocompatibility Testing | Hematopoietic Stem Cell Transplantation | Terminology as Topic | Consensus | Graft vs Host Disease - pathology | Adolescent | Survival Analysis | Hematologic Neoplasms - immunology | Tissue Donors | Chronic Disease | Patient outcomes | Mortality | Stem cells | Transplantation | Health aspects | Morbidity | Hematopoietic stem cells
Journal Article